表紙
市場調査レポート - 237444

動脈瘤:世界の治験動向

Aneurysm Global Clinical Trials Review, H1, 2015

発行 GlobalData
出版日 ページ情報 英文 91 Pages
電子版即納可
価格
Back to Top
動脈瘤:世界の治験動向 Aneurysm Global Clinical Trials Review, H1, 2015
出版日: 2015年03月31日 ページ情報: 英文 91 Pages
概要

当レポートでは、動脈瘤の臨床試験に関する基本情報やデータを提供しており、地域別、段階別、進捗状況別の実施件数、代表的なスポンサー、開発中の治療薬の情報、世界各国の主要企業・機関での臨床試験の進捗状況、有望な薬剤の比較といった情報をお届けします。

イントロダクション

  • 動脈瘤
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:心血管系治療薬の治験における動脈瘤の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管系治療薬の治験における動脈瘤の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

動脈瘤治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Novartis AG
    • NoNO, Inc.
    • Sanofi
    • Johnson & Johnson
    • Hope Pharmaceuticals, Inc.
    • Fresenius Kabi AG
    • Edge Therapeutics, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Leiden University Medical Center
    • Assistance Publique - Hopitaux de Paris
    • 日本大学
    • Tohoku University School of Medicine
    • Academic Medical Center
    • Centre Hospitalier Universitaire de Nice
    • Duke University
    • Hospital Israelita Albert Einstein
    • Imperial College London
    • James Cook University

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Aneurysm Global Clinical Trials Review, H1, 2015" provides data on the Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aneurysm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Aneurysm
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Aneurysm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Aneurysm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Aneurysm
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Aneurysm Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • NoNO, Inc.
      • Clinical Trial Overview of NoNO, Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Hope Pharmaceuticals, Inc.
      • Clinical Trial Overview of Hope Pharmaceuticals, Inc.
      • Fresenius Kabi AG
      • Clinical Trial Overview of Fresenius Kabi AG
      • Edge Therapeutics, Inc.
      • Clinical Trial Overview of Edge Therapeutics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Nihon University
      • Clinical Trial Overview of Nihon University
      • Tohoku University School of Medicine
      • Clinical Trial Overview of Tohoku University School of Medicine
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Centre Hospitalier Universitaire de Nice
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Nice
      • Duke University
      • Clinical Trial Overview of Duke University
      • Hospital Israelita Albert Einstein
      • Clinical Trial Overview of Hospital Israelita Albert Einstein
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • James Cook University
      • Clinical Trial Overview of James Cook University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Aneurysm Therapeutics, Global, Clinical Trials by Region, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Aneurysm Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Aneurysm Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Aneurysm Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Aneurysm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by NoNO, Inc., 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hope Pharmaceuticals, Inc., 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Kabi AG, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University School of Medicine, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Israelita Albert Einstein, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by James Cook University, 2015*

List of Figures

  • Aneurysm Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Aneurysm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top